000 | 01987 a2200457 4500 | ||
---|---|---|---|
005 | 20250513222702.0 | ||
264 | 0 | _c20001130 | |
008 | 200011s 0 0 eng d | ||
022 | _a0278-6915 | ||
024 | 7 |
_a10.1016/s0278-6915(00)00101-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChuang, S E | |
245 | 0 | 0 |
_aInhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. _h[electronic resource] |
260 |
_bFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association _cNov 2000 |
||
300 |
_a991-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCDC2 Protein Kinase _xantagonists & inhibitors |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmetabolism |
650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdrug therapy |
650 | 0 | 4 |
_aCurcumin _xtherapeutic use |
650 | 0 | 4 |
_aDiethylnitrosamine _xtoxicity |
650 | 0 | 4 |
_aHyperplasia _xdrug therapy |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Neoplasms _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aOncogene Protein p21(ras) _xantagonists & inhibitors |
650 | 0 | 4 |
_aOrgan Size _xdrug effects |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xantagonists & inhibitors |
700 | 1 | _aCheng, A L | |
700 | 1 | _aLin, J K | |
700 | 1 | _aKuo, M L | |
773 | 0 |
_tFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association _gvol. 38 _gno. 11 _gp. 991-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0278-6915(00)00101-0 _zAvailable from publisher's website |
999 |
_c10983286 _d10983286 |